Search Results for ''

published presentations and documents on DocSlides.

Biomarker Development and Validation
Biomarker Development and Validation
by lois-ondreau
Practices & Experiences. Shawn Li, M.D., Ph.D...
Molecular Subtypes:
Molecular Subtypes:
by giovanna-bartolotta
Not Quite Ready . for Prime Time. Scott Kopetz, M...
Breakout Session 4: Personalized Medicine and Subgroup Sele
Breakout Session 4: Personalized Medicine and Subgroup Sele
by trish-goza
Christopher . Jennison. , University of Bath. Rob...
Precision Medicine Clinical Trial Designs
Precision Medicine Clinical Trial Designs
by luanne-stotts
2018 . AACR Annual Meeting. April 15, 2018 . Edwa...
ADNI 3 plans for Biomarker Core
ADNI 3 plans for Biomarker Core
by luanne-stotts
Leslie M Shaw & John Q . Trojanowski. Magdale...
Welcome to Workshop #5:
Welcome to Workshop #5:
by ruby
Accelerated Approval (AA) in Rare Diseases:. Revie...
Phase II designs in Oncology
Phase II designs in Oncology
by stefany-barnette
Nick . Pavlakis. , MBBS, . MMed. (. Clin. Epi. ...
FDA Regulatory Requirements for Successful Biomarker Applications
FDA Regulatory Requirements for Successful Biomarker Applications
by oliver
Early Detection Research Network. September 9, 201...
Biomarkers in the Brain Oxygen Optimization in Severe TBI Study
Biomarkers in the Brain Oxygen Optimization in Severe TBI Study
by miller
PIs. : . Ramon Diaz-Arrastia, M.D., Ph.D. . and . ...
Biomarkers redux? Laura J. Niedernhofer, M.D., Ph.D.
Biomarkers redux? Laura J. Niedernhofer, M.D., Ph.D.
by eleanor
Optimist. Department of Biochemistry, Molecular Bi...
Hypoalbuminaemia  as a possible biomarker of gastro-intestinal lymphoma in cats
Hypoalbuminaemia as a possible biomarker of gastro-intestinal lymphoma in cats
by sherrill-nordquist
R. Lobetti. 1,2. , E. Lindquist. 2. , . C.Berman....
Personalised Medicine in practice in The Netherlands – a
Personalised Medicine in practice in The Netherlands – a
by calandra-battersby
T. Kievits . Director Vitromics Healthcare Holdin...